← Eichor
Study identifier: NCT06433648 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Understanding How Powered Componentry Impacts K2-Level Transfemoral Amputee Gait

Condition: Amputation · Amputation, Traumatic · Amputation of Knee  ·  Sponsor: Shirley Ryan AbilityLab

PhaseNA
Planned participants20
Who can joinAll sexes, 18 Years to 95 Years
Healthy volunteersNo

About this study

The goal of this study is to understand how providing power at the knee or ankle individually, or providing power at both the knee and ankle, impacts ambulation for K2 level transfemoral amputees. Aim 1: measure functional performance of K2 level ambulators when using a commercially available passive microprocessor knee prosthesis (Ottobock Cleg/Ottobock foot) or a powered knee and ankle prosthesis (SRALab Hybrid Knee and SRAlab Polycentric Powered Ankle. Aim 2: Participants will be evaluated on the contribution of adding power at the knee only or the ankle only. Aim 3: The investigators will evaluate the functional performance after intensive clinical gait training on the powered knee and ankle prosthesis (SRALab Hybrid Knee and SRALab Polycentric Powered Ankle). Our hypothesis is that providing powered componentry will improve function and that intensive training will magnify those improvements.

This description comes directly from the study's public registry record.

Talk to the study team

Suzanne Finucane, MS, PTA  ·  312-238-0937  ·  sfinucane@sralab.org

Levi Hargrove, PhD  ·  312-238-2080  ·  lhargrove@sralab.org

Always discuss trial participation with your own doctor first.

Locations (1)

Shirley Ryan AbilityLabChicago, Illinois, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06433648